Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats. 1994

K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Japan.

We examined the role of the sympathetic nervous system in the antihypertensive effect of long-term (4-week) administration of cicletanine (50 mg/100 g in diet) in young (6 week-old) spontaneously hypertensive rats (SHR) fed an 8.0% salt-containing diet. Salt loading accelerated the development of hypertension in young SHR (mean blood pressure [BP]: 158 +/- 3 v 196 +/- 5 mm Hg, P < .01). Although cicletanine did not affect mean BP in non-salt-loaded SHR, it reversed salt-induced hypertension (155 +/- 3 mm Hg, P < .01). Salt loading elevated plasma norepinephrine (NE) (246 +/- 16 v 451 +/- 87 pg/mL, P < .05) but simultaneous administration of cicletanine inhibited the increase in plasma NE with salt loading (234 +/- 12 pg/mL, P < .01). Hexamethonium, a ganglionic blocking agent, produced a greater hypotensive effect in salt-loaded than in non-salt-loaded SHR (-40 +/- 4 v -78 +/- 4 mm Hg, P < .01). In salt-loaded SHR with cicletanine, however, the hypotensive effect of hexamethonium was suppressed compared with salt-loaded SHR without cicletanine (-52 +/- 4 mm Hg, P < .01). Both plasma NE (r = 0.608, P < .01) and decrease in mean BP with hexamethonium (r = -0.798, P < .01) correlated with baseline mean BP. Thus, cicletanine inhibited the salt-induced rise in mean BP of young SHR, possibly through the suppression of enhanced sympathetic nerve activity.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
February 1987, Clinical and experimental pharmacology & physiology,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
June 1973, Japanese circulation journal,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
September 1995, Journal of hypertension,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
February 1997, British journal of pharmacology,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
January 1980, Hypertension (Dallas, Tex. : 1979),
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
January 1985, Hypertension (Dallas, Tex. : 1979),
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
August 1995, British journal of pharmacology,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
July 1989, Hypertension (Dallas, Tex. : 1979),
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
April 1996, Journal of cardiovascular pharmacology,
K Ando, and A Ono, and Y Sato, and S Asano, and T Fujita
January 2012, International journal of molecular sciences,
Copied contents to your clipboard!